1.Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor–Positive and HER-2–Negative Breast Cancer with Neoadjuvant Chemotherapy
Eun-Gyeong LEE ; Dong-Eun LEE ; Hyun hee KIM ; Jai Hong HAN ; Seeyoun LEE ; Han-Sung KANG ; Eun Sook LEE ; Heejung CHAE ; Sung Hoon SIM ; Keun Seok LEE ; Youngmee KWON ; So-Youn JUNG
Cancer Research and Treatment 2023;55(2):542-550
Purpose:
This study investigated pathological complete response (pCR) according to androgen receptor (AR) in breast cancer patients undergoing neoadjuvant chemotherapy and estimated the relationship between AR expression and clinicopathological factors.
Materials and Methods:
We identified 624 breast cancer patients who underwent surgery after neoadjuvant chemotherapy at the National Cancer Center in Goyang, Korea from April 2016 to October 2019. We retrospectively collected the clinicopathologic information and AR expression results and analyzed the data according to cancer stage, hormonal receptor (HR) status, human epidermal growth factor receptor 2 (HER2) status, tumor subtype, and pCR.
Results:
Among the 624 breast cancer patients, 529 (84.8%) were AR-positive (AR+) patients and 95 (15.2%) were AR-negative (AR–) patients. AR+ patients showed more estrogen receptor (ER) positivity, progesterone receptor (PR) positivity, HER2-positivity, and HR-positive and HER2-negative (HR+/HER2–) subtype. The rate of pCR was 31.4% (196/624). AR– patients had a significantly higher rate of pCR than AR+ patients (AR– 43.2% vs. AR+ 29.3%, p=0.007). The tumor factors associated with pCR were early stage, histologic grade 3, ER-negative, PR-negative, AR-negative, HER2-positive, and high Ki-67 values. In univariable analysis, AR+ significantly decreased the state of pCR (odds ratio, 0.546; 95% confidence interval, 0.349 to 0.853; p=0.008). According to tumor subtype, AR– tumor showed higher pCR rate in HR+/HER2– subtype (AR– 28.6% vs. AR+ 7.3%, p=0.022).
Conclusion
AR expression is predominant in the HR+/HER2– subtype. AR– is significantly associated with the pCR rate in breast cancer patients, especially within HR+/HER2– subtype. When determining neoadjuvant chemotherapy for the HR+/HER2– subtype, AR expression can be considered as a pCR predictive marker.
2.Multidisciplinary Shared Decision Making for Fertility Preservation in Young Women With Breast Cancer
Soo Yeon BAEK ; Hong-Kyu KIM ; Seho PARK ; Jong Han YU ; Min Hyuk LEE ; Hyun Jo YOUN ; Hyun-Ah KIM ; Jai Hong HAN ; Jung Eun CHOI ; Jung Ryeol LEE ; Kyung-Hun LEE ; Seockhoon CHUNG ; Hee Dong CHAE ; Seonok KIM ; Soyoung YOO ; Sang Keun HAHM ; Hee Jeong KIM
Journal of Breast Cancer 2023;26(6):582-592
Purpose:
Fertility preservation (FP) is an important issue for young survivors of breast cancer. Although international guidelines recommend pre-treatment fertility counseling for women with breast cancer, there is no standardized protocol or referral system for FP in South Korea. There are also barriers to discussing FP that make patient-centered decision making difficult. This study aimed to develop a shared decision making program for FP and compare the rates of FP procedures between the usual care and shared decision making groups. We hypothesized that multidisciplinary shared decision making for FP would increase the rate of FP procedures and patient satisfaction.
Methods
The multidisciplinary shared decision making for FP in young women with breast cancer (MYBC) is a multicenter, clustered, stepped-wedge, randomized trial. A total of 1100patients with breast cancer, aged 19–40 years, from nine hospitals in South Korea, will be enrolled. They will be randomized at the institutional level and assigned to usual care and shared decision making groups. Four institutions, each of which can recruit more than 200 patients, will each become a cluster, whereas five institutions, each of which can recruit more than 50 patients, will become one cluster, for a total of five clusters. The shared decision making groups will receive multidisciplinary programs for FP developed by the investigator. The primary outcome is the rate of FP procedures; secondary outcomes include fertility results, satisfaction, and quality of life. Outcomes will be measured at enrollment, treatment initiation, and the 1-, 3-, and 5-year follow-ups after starting breast cancer treatment.Discussion: A multidisciplinary shared decision making program for FP is expected to increase fertility rates and satisfaction among young patients with breast cancer. This study will provide the evidence to implement a multidisciplinary system for patients with breast cancer.
3.Risk Prediction Model Based on Magnetic Resonance Elastography-Assessed Liver Stiffness for Predicting Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma
Hyo Jung CHO ; Young Hwan AHN ; Min Suh SIM ; Jung Woo EUN ; Soon Sun KIM ; Bong Wan KIM ; Jimi HUH ; Jei Hee LEE ; Jai Keun KIM ; Buil LEE ; Jae Youn CHEONG ; Bohyun KIM
Gut and Liver 2022;16(2):277-289
Background/Aims:
Posthepatectomy liver failure (PHLF) is a major complication that increases mortality in patients with hepatocellular carcinoma after surgical resection. The aim of this retrospective study was to evaluate the utility of magnetic resonance elastography-assessed liver stiffness (MRE-LS) for the prediction of PHLF and to develop an MRE-LS-based risk prediction model.
Methods:
A total of 160 hepatocellular carcinoma patients who underwent surgical resection with available preoperative MRE-LS data were enrolled. Clinical and laboratory parameters were collected from medical records. Logistic regression analyses were conducted to identify the risk factors for PHLF and develop a risk prediction model.
Results:
PHLF was present in 24 patients (15%). In the multivariate logistic analysis, high MRE-LS (kPa; odds ratio [OR] 1.49, 95% confidence interval [CI] 1.12 to 1.98, p=0.006), low serum albumin (≤3.8 g/dL; OR 15.89, 95% CI 2.41 to 104.82, p=0.004), major hepatic resection (OR 4.16, 95% CI 1.40 to 12.38, p=0.014), higher albumin-bilirubin score (>–0.55; OR 3.72, 95% CI 1.15 to 12.04, p=0.028), and higher serum α-fetoprotein (>100 ng/mL; OR 3.53, 95% CI 1.20 to 10.40, p=0.022) were identified as independent risk factors for PHLF. A risk prediction model for PHLF was established using the multivariate logistic regression equation. The area under the receiver operating characteristic curve (AUC) of the risk prediction model was 0.877 for predicting PHLF and 0.923 for predicting grade B and C PHLF. In leave-one-out cross-validation, the risk model showed good performance, with AUCs of 0.807 for all-grade PHLF and 0. 871 for grade B and C PHLF.
Conclusions
Our novel MRE-LS-based risk model had excellent performance in predicting PHLF, especially grade B and C PHLF.
4.J-curve relationship between corrected QT interval and mortality in acute heart failure patients
Chan Soon PARK ; Hyun-Jai CHO ; Eue-Keun CHOI ; Sang Eun LEE ; Min-Seok KIM ; Jae-Joong KIM ; Jin-Oh CHOI ; Eun-Seok JEON ; Kyung-Kuk HWANG ; Shung Chull CHAE ; Sang Hong BAEK ; Seok-Min KANG ; Byungsu YOO ; Dong-Ju CHOI ; Youngkeun AHN ; Kye-Hoon KIM ; Myeong-Chan CHO ; Byung-Hee OH ; Hae-Young LEE
The Korean Journal of Internal Medicine 2020;35(6):1371-1384
Background/Aims:
This study investigated the prognostic power of corrected QT (QTc) interval in patients with acute heart failure (AHF) according to sex.
Methods:
We analyzed multicenter Korean Acute Heart Failure registry with patients with AHF admitted from 2011 to 2014. Among them, we analyzed 4,990 patients who were followed up to 5 years. Regarding QTc interval based on 12 lead electrocardiogram, patients were classified into quartiles according to sex.
Results:
During follow-up with median 43.7 months, 2,243 (44.9%) patients died. The relationship between corrected QT interval and all-cause mortality followed a J-curve relationship. In Kaplan-Meier analysis, both sex had lowest mortality in the second QTc quartile. There were significant prognostic differences between the second and the fourth quartiles in male (log-rank p = 0.002), but not in female (log-rank p = 0.338). After adjusting covariates, the third (hazard ratio [HR], 1.185; 95% confidence interval [CI], 1.001 to 1.404; p = 0.049) and the fourth (HR, 1.404; 95% CI, 1.091 to 1.535; p = 0.003) quartiles demonstrated increased risk of mortality compared to the second quartile in male. In female, however, there was no significant difference across quartiles. QTc interval was associated with 5-year all-cause mortality in J-shape with nadir of 440 to 450 ms in male and 470 to 480 ms in female.
Conclusions
QTc interval was an independent predictor of overall death in male, but its significance decreased in female. The relationship between QTc interval and all-cause mortality was J-shaped in both sex.
5.Gastrointestinal Gas and Abdominal Fat Quantity Measured by Three-Dimensional Abdominal Computed Tomography in Patients with Functional Bloating.
Hong Sub LEE ; Jai Keun KIM ; Joo Sung SUN ; Kwang Jae LEE
The Korean Journal of Gastroenterology 2018;71(6):324-331
BACKGROUND/AIMS: The aim of this study was to assess whether increased intestinal gas or fat content in the abdominal cavity is related to abdominal bloating, using three-dimensional abdominal computed tomography scan. METHODS: Twenty-nine healthy individuals without abdominal bloating and organic disease (15 women; mean age, 49 years; range of age, 23–73 years) and 30 patients with chronic recurrent abdominal bloating-diagnosed with functional bloating (10 women; mean age, 53 years; range of age, 35–75 years) - participated in this study. The mean values of measured parameters were compared using independent sample t-test. RESULTS: The mean volume of total colon gas in bloated patients was similar to that in control subjects. The distribution of intra-abdominal gas was also similar between the two groups. However, the amount of gas in the transverse colon tended to be significantly higher in patients with bloating than in controls (p=0.06). Body mass index was similar between the two groups (23.4±3.2 kg/m2 and 22.3±3.1 kg/m2, respectively). Moreover, no significant differences with respect to circumferential area, subcutaneous fat, visceral fat area, and total fat area were found between the two groups. CONCLUSIONS: Bloating might not just be the result of gastrointestinal gas or intra-abdominal fat. Other contributing factors, such as localized abnormality in gas distribution and visceral hypersensitivity, may be involved.
Abdominal Cavity
;
Abdominal Fat*
;
Body Mass Index
;
Colon
;
Colon, Transverse
;
Female
;
Gastrointestinal Contents
;
Humans
;
Hypersensitivity
;
Intra-Abdominal Fat
;
Irritable Bowel Syndrome
;
Multidetector Computed Tomography
;
Subcutaneous Fat
6.Effectiveness and Safety of Biolimus A9™-Eluting stEnt in Patients with AcUTe Coronary sYndrome; A Multicenter, Observational Study (BEAUTY Study)
Keun Ho PARK ; Myung Ho JEONG ; Young Joon HONG ; Youngkeun AHN ; Hyun Kuk KIM ; Young Yub KOH ; Doo Il KIM ; Sang Wook KIM ; Weon KIM ; Seung Woon RHA ; Jay Young RHEW ; Jong Seon PARK ; Hun Sik PARK ; Jang Ho BAE ; Jang Whan BAE ; Seok Kyu OH ; Sung Yun LEE ; Seung Wook LEE ; Jae Hwan LEE ; Sang Yeob LIM ; Jang Hyun CHO ; Kwang Soo CHA ; Jai Keon CHAE ; Seung Ho HUR ; Sun Ho HWANG ; Jin Yong HWANG
Yonsei Medical Journal 2018;59(1):72-79
PURPOSE: This study sought to determine the 1-year clinical effectiveness and safety of a biodegradable, polymer-containing Biolimus A9™-eluting stent (BES) in Korean patients with acute coronary syndrome (ACS). MATERIALS AND METHODS: A total of 1000 ACS patients with 1251 lesions who underwent implantation of BESs at 22 centers in Korea were enrolled between May 2011 and July 2013. We assessed major adverse cardiac events (MACE) defined as the composite of cardiac death, non-fatal myocardial infarction (MI), and clinical-driven target vessel revascularization at 12 months. RESULTS: Patient mean age was 62.6±11.4 years. 72.8% of the patients were male, 28.5% had diabetes, 32.8% had multi-vessel disease (MVD), and 47.9% presented with acute MI (AMI). The mean global registry of acute coronary events risk score of all patients was 103.0±27.6. The number of stents per patient was 1.3±0.6. The incidences of MACE and definite stent thrombosis at 12 months were 3.9% and 0.2%, respectively. On multivariate Cox-regression analysis, age ≥65 years was identified as an independent predictors of 1-year MACE (hazard ratio=2.474; 95% confidence interval=1.202−5.091). Subgroup analyses revealed no significant differences in the incidence of MACE between patients with and without diabetes (4.3% vs. 3.7%, p=0.667), between those who presented with and without AMI (4.4% vs. 3.4%, p=0.403), and between those with and without MVD (4.6% vs. 3.5%, p=0.387). CONCLUSION: Our study demonstrated excellent 1-year clinical outcomes of BES implantation in patients at low-risk for ACS.
Acute Coronary Syndrome/drug therapy
;
Aged
;
Drug-Eluting Stents/adverse effects
;
Female
;
Humans
;
Incidence
;
Kaplan-Meier Estimate
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Proportional Hazards Models
;
Republic of Korea
;
Sirolimus/adverse effects
;
Sirolimus/analogs & derivatives
;
Sirolimus/therapeutic use
;
Time Factors
;
Treatment Outcome
7.Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
Soon Sun KIM ; Hyo Jung CHO ; Ji Sun NAM ; Hyun Ji KIM ; Dae Ryong KANG ; Je Hwan WON ; Jinoo KIM ; Jai Keun KIM ; Jei Hee LEE ; Bo Hyun KIM ; Mi Young LEE ; Sung Won CHO ; Jae Youn CHEONG
Journal of Korean Medical Science 2018;33(1):e6-
BACKGROUND: We investigated an association between the levels of plasma microRNA (miRNA)-21,
Carcinoma, Hepatocellular
;
Chemoembolization, Therapeutic
;
Follow-Up Studies
;
Hepatitis B, Chronic
;
Humans
;
Liver Transplantation
;
MicroRNAs
;
Multivariate Analysis
;
Plasma
;
Real-Time Polymerase Chain Reaction
8.Localized Adenomyomatosis of Gallbladder Mimicking Advanced Hepatic Flexure Colon Cancer: A Case Report
Pae Sun SUH ; Bohyun KIM ; Dakeun LEE ; Ki Myung LEE ; Jei Hee LEE ; Hye Jin KIM ; Jai Keun KIM
Journal of the Korean Radiological Society 2018;79(5):290-293
Localized forms of gallbladder adenomyomatosis are rarely polypoid and may mimic gallbladder cancer. Herein, we present a unique case of polypoid gallbladder adenomyomatosis penetrating the colon and preoperatively misdiagnosed as advanced hepatic flexure colon cancer.
9.Effect of zirconia surface treatment using nitric acid-hydrofluoric acid on the shear bond strengths of resin cements.
Jin Hyung CHO ; Sun Jai KIM ; June Sung SHIM ; Keun Woo LEE
The Journal of Advanced Prosthodontics 2017;9(2):77-84
PURPOSE: The aim of this study was to compare the surface roughness of zirconia when using Zircos E etching system (ZSAT), applying a nitric acid-hydrofluoric acid compound as a pretreatment agent, and also to compare the shear bonding strength according to different resin cements. MATERIALS AND METHODS: ZSAT, air abrasion, and tribochemical silicacoating were applied on prepared 120 zirconia specimens (10 mm in diameter, 7 mm in height) using CAD/CAM. Each 12 specimens with 4 different resin cements (Panavia F 2.0, Rely X Unicem, Superbond C&B, and Hot bond) were applied to test interfacial bond strength. The statistical analysis was performed using SAS 9.1 (SAS Institute Inc., Cary, NC, USA). The results are as follows: after application of the ZSAT on the zirconia specimens, surface roughness value after 2-hour etching was higher than those after 1- and 3-hour etching on SEM images. RESULTS: For Superbond C&B and Rely X Unicem, the specimens treated with ZSAT showed higher shear bond strength values than those treated with air abrasion and tribochemical silicacoating system. Regarding the failure mode of interface over cement and zirconia surface, Rely X Unicem and Hot bond showed cohesive failures and Panavia F 2.0 and Superbond C&B showed mixed failures. CONCLUSION: Zircos E etching system in zirconia restoration could increase its shear bond strength. However, its long term success rate and clinical application should be further evaluated.
Adhesives
;
Resin Cements*
10.Influencing factors on postoperative hospital stay after laparoscopic cholecystectomy.
Jae Uk CHONG ; Jin Ho LEE ; Young Chul YOON ; Kuk Hwan KWON ; Jai Young CHO ; Say Jun KIM ; Jae Keun KIM ; Sung Hoon KIM ; Sae Byeol CHOI ; Kyung Sik KIM
Korean Journal of Hepato-Biliary-Pancreatic Surgery 2016;20(1):12-16
BACKGROUNDS/AIMS: Laparoscopic cholecystectomy can reduce postoperative pain and recovery time. However, some patients experience prolonged postoperative hospital stay. We aimed to identify factors influencing the postoperative hospital stay after laparoscopic cholecystectomy. METHODS: Patients (n=336) undergoing laparoscopic cholecystectomy for gallbladder pathology at 8 hospitals were enrolled and divided into 2 groups: 2 or less and more than 2 days postoperative stay. Perioperative factors and patient factors were retrospectively analyzed. RESULTS: The patient population median age was 52 years, and consisted of 32 emergency and 304 elective operations. A univariate analysis of perioperative factors revealed significant differences in operation time (p<0.001), perioperative transfusion (p=0.006), emergency operation (p<0.001), acute inflammation (p<0.001), and surgical site infection (p=0.041). A univariate analysis of patient factors revealed significant differences in age (p<0.001), gender (p=0.036), diabetes mellitus (p=0.011), preoperative albumin level (p=0.024), smoking (p=0.010), and American Society of Anesthesiologists score (p=0.003). In a multivariate analysis, operation time (p<0.001), emergency operation (p<0.001), age (p=0.014), and smoking (p=0.022) were identified as independent factors influencing length of postoperative hospital stay. CONCLUSIONS: Operation time, emergency operation, patient age, and smoking influenced the postoperative hospital stay and should be the focus of efforts to reduce hospital stay after laparoscopic cholecystectomy.
Cholecystectomy, Laparoscopic*
;
Diabetes Mellitus
;
Emergencies
;
Gallbladder
;
Humans
;
Inflammation
;
Length of Stay*
;
Multivariate Analysis
;
Pain, Postoperative
;
Pathology
;
Postoperative Complications
;
Retrospective Studies
;
Smoke
;
Smoking

Result Analysis
Print
Save
E-mail